USPTO TTABVUE. Trademark Trial and Appeal Board Inquiry System

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

TTABVUE. Trademark Trial and Appeal Board Inquiry System

v2.5.0

Summary

Query: Party Name contains all words: NOVARTIS AG
Number of results: 100+
Results are in reverse chronological order

Proceeding
Filing Date

Defendant(s),
Property(ies)

Plaintiff(s),
Property(ies)

98415752
11/21/2024

AOTU TECHNOLOGY CO.,LTD
Mark: VINSIC S#:98415752

Novartis AG

98387696
11/05/2024

NNOVAR LLC
Mark: NNOVAR S#:98387696

Novartis AG

79394512
10/28/2024

Novartis AG
Mark: REVPEM S#:79394512

98468938
10/11/2024

Elevar Therapeutics, Inc.
Mark: TULVEGIO S#:98468938

NOVARTIS AG

98433469
07/08/2024

Omeros Corporation
Mark: VIQUIO S#:98433469

Novartis AG

98433468
06/26/2024

Omeros Corporation
Mark: VYLODIA S#:98433468

Astellas Pharma Inc.
Novartis AG

79362246
06/25/2024

STEMON Inc.
Mark: ENTR S#:79362246

Novartis AG

97861523
02/13/2024

Advanced Humeomics LLC
Mark: NOVARI S#:97861523

Novartis AG

97724835
11/28/2023

EyePoint Pharmaceuticals US, Inc.
Mark: DURAMAC S#:97724835

Novartis AG

97767088
11/28/2023

EyePoint Pharmaceuticals US, Inc.
Mark: DURAVUE S#:97767088

Novartis AG

98048453
11/28/2023

EyePoint Pharmaceuticals US, Inc.
Mark: DURVUE S#:98048453

Novartis AG

98048464
11/28/2023

EyePoint Pharmaceuticals US, Inc.
Mark: DURVIEW S#:98048464

Novartis AG

98073717
11/28/2023

EyePoint Pharmaceuticals US, Inc.
Mark: DURAVYU S#:98073717

Novartis AG

97724740
11/28/2023

EyePoint Pharmaceuticals US, Inc.
Mark: DURAVU S#:97724740

Novartis AG

97648335
10/05/2023

TEVA PHARMACEUTICALS USA, Inc.
Mark: WILPAXA S#:97648335

Novartis AG

91287397
09/28/2023

Amgen Inc.
Mark: PAVBLU S#:97353493

Novartis AG
Mark: PAVCUE S#:79350630 R#:6982665

97552839
08/02/2023

Novara LLC
Mark: NOVARA S#:97552839

Novartis AG

79361196
07/20/2023

NOVARTIS AG
Mark: STACANTO S#:79361196

Alexza Pharmaceuticals, Inc.

79367968
07/19/2023

NOVARTIS AG
Mark: HAVLUMIO S#:79367968

Genentech, Inc.

97206106
06/13/2023

Novalis LifeSciences LLC
Mark: NOVALIS S#:97206106

Novartis AG

97513825
06/13/2023

ST. PAUL BRANDS, INC.
Mark: NOFATIC S#:97513825

Novartis AG

79336608
05/17/2023

Aioneers GmbH
Mark: AIONEERS S#:79336608

Novartis AG

97772530
05/16/2023

Reckitt & Colman (Overseas) Health Limited
Mark: OPTREX S#:97772530

Novartis AG

97353493
04/27/2023

Amgen Inc.
Mark: PAVBLU S#:97353493

Novartis AG

97372166
03/23/2023

TEVA PHARMACEUTICALS USA, Inc.
Mark: HYKALI S#:97372166

Novartis AG